Desheva Y, Sergeeva M, Kudar P, Rekstin A, Romanovskaya-Romanko E, Krivitskaya V
Vaccines (Basel). 2025; 12(12.
PMID: 39771996
PMC: 11680112.
DOI: 10.3390/vaccines12121334.
Rajendran M, Krammer F, McMahon M
Vaccines (Basel). 2021; 9(8).
PMID: 34451971
PMC: 8402431.
DOI: 10.3390/vaccines9080846.
Vieira M, Donato C, Arevalo P, Rimmelzwaan G, Wood T, Lopez L
Nat Commun. 2021; 12(1):4313.
PMID: 34262041
PMC: 8280188.
DOI: 10.1038/s41467-021-24566-y.
Smith G, Sun X, Bai Y, Liu Y, Massare M, Pearce M
Virology. 2017; 509:90-97.
PMID: 28624679
PMC: 5788299.
DOI: 10.1016/j.virol.2017.06.006.
Uekermann F, Sneppen K
Sci Rep. 2016; 6:25907.
PMID: 27174658
PMC: 4865727.
DOI: 10.1038/srep25907.
Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.
Petrie J, Ohmit S, Johnson E, Truscon R, Monto A
J Infect Dis. 2015; 212(12):1914-22.
PMID: 26014800
PMC: 4655854.
DOI: 10.1093/infdis/jiv313.
Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva Y, Smolonogina T, Donina S, Rudenko L
BMC Res Notes. 2015; 8:136.
PMID: 25889924
PMC: 4399204.
DOI: 10.1186/s13104-015-1086-z.
Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.
Marcelin G, Sandbulte M, Webby R
Rev Med Virol. 2012; 22(4):267-79.
PMID: 22438243
PMC: 3389592.
DOI: 10.1002/rmv.1713.
Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza.
Chan K, To K, Hung I, Zhang A, Chan J, Cheng V
Clin Vaccine Immunol. 2011; 18(5):867-73.
PMID: 21411604
PMC: 3122523.
DOI: 10.1128/CVI.00555-10.
Influenza B at Christ's Hospital: natural antibody to influenza B estimated by radial haemolysis.
Grilli E, Davies J
J Hyg (Lond). 1981; 87(2):211-8.
PMID: 7026670
PMC: 2134045.
DOI: 10.1017/s0022172400069424.
Influenza A: infection and reinfection.
Davies J, Grilli E, Smith A
J Hyg (Lond). 1984; 92(1):125-7.
PMID: 6693762
PMC: 2129348.
DOI: 10.1017/s002217240006410x.
The use of a radial haemolysis test for neuraminidase antibodies in the diagnosis of influenza A infection.
Grilli E, Smith A
J Hyg (Lond). 1983; 91(1):147-56.
PMID: 6350441
PMC: 2129295.
DOI: 10.1017/s0022172400060125.
Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses.
Davies J, Grilli E
Epidemiol Infect. 1989; 102(2):325-33.
PMID: 2703026
PMC: 2249427.
DOI: 10.1017/s0950268800030004.
Recent experience of influenza.
Sparks J
J R Coll Physicians Lond. 1978; 12(5):437-49.
PMID: 731619
PMC: 5366678.
Cross-protection in mice after immunization with H2N2, H3N2, and Heq2Neq2 influenza virus strains.
Anker W, Bakker A, Masurel N
Infect Immun. 1978; 21(1):96-101.
PMID: 711325
PMC: 421962.
DOI: 10.1128/iai.21.1.96-101.1978.
Single radial haemolysis: a survey of antibody titres in the highland region of Scotland to recent strains of influenza A.
Joss A, McPherson J, Williams H
J Hyg (Lond). 1978; 80(1):1-11.
PMID: 621377
PMC: 2129987.
DOI: 10.1017/s0022172400053341.
The use of transportable single-radial-diffusion immunoplates in seroepidemiological studies of influenza in the Gambia. The occurrence and persistence of antibody to influenza A/Hong Kong/68 (H3N2) virus in selected inhabitants of two rural villages.
Schild G, Newman R, McGregor I, Williams K
Bull World Health Organ. 1977; 55(1):3-13.
PMID: 408021
PMC: 2366616.
The response to inactivated influenza A (H3N2) vaccines: the development and effect of antibodies to the surface antigens.
Smith A, Davies J
J Hyg (Lond). 1977; 78(3):363-75.
PMID: 266540
PMC: 2129882.
DOI: 10.1017/s0022172400056266.